Immunic Stock In The News

IMUX Stock  USD 1.17  0.01  0.86%   
Our overall analysis of Immunic's news coverage and content from conventional and social sources shows investors' bearish mood towards Immunic. The specific impact of Immunic news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Immunic's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Immunic headlines in addition to utilizing other, more conventional financial analysis modules. Check out Immunic Backtesting and Immunic Hype Analysis.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Immunic Today Top News and Investor Outlook

Yahoo News
Immunic, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
https://finance.yahoo.com/news/immunic-inc-reports-second-quarter-103000296.html
 Bullish
Yahoo News
Immunic to Participate in Investor and Scientific Conferences in August
https://finance.yahoo.com/news/immunic-participate-investor-scientific-conferences-103000871.html
 Neutral
Yahoo News
10 Best Rated Penny Stocks to Buy According to Analysts
https://finance.yahoo.com/news/10-best-rated-penny-stocks-201933784.html
 Bullish
Yahoo News
Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2023, and Provide Corporate Update
https://finance.yahoo.com/news/immunic-inc-announce-financial-results-103000703.html
 Neutral
Yahoo News
Immunic Inc eyeing "big step" for multiple sclerosis patients
https://finance.yahoo.com/news/immunic-inc-eyeing-big-step-120000301.html
 Bullish
Yahoo News
With 50% stake, Immunic, Inc. (NASDAQ:IMUX) seems to have captured institutional investors' interest
https://finance.yahoo.com/news/50-stake-immunic-inc-nasdaq-143341989.html
 Bullish
Yahoo News
Immunic to Participate in Scientific and Investor Conferences in July
https://finance.yahoo.com/news/immunic-participate-scientific-investor-conferences-103000541.html
 Neutral
Yahoo News
These 2 ‘Strong Buy’ Penny Stocks Could Soar to $25 (Or Higher), Says Piper Sandler
https://finance.yahoo.com/news/2-strong-buy-penny-stocks-135603450.html
 Bullish
Yahoo News
Pleasing Signs As A Number Of Insiders Buy Immunic Stock
https://finance.yahoo.com/news/pleasing-signs-number-insiders-buy-131122769.html
 Bullish
Yahoo News
Immunic Therapeutics shares IMU-856 mode of action and target for gastrointestinal diseases
https://finance.yahoo.com/news/immunic-therapeutics-shares-imu-856-194404707.html
 Bullish

Immunic Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Immunic and other traded companies coverage with news coverage. We help investors stay connected with Immunic headlines for the 5th of March to make an informed investment decision based on correlating the impacts of news items on Immunic Stock performance. Please note that trading solely based on the Immunic hype is not for everyone as timely availability and quick action are needed to avoid losses.
Immunic's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Immunic investors visualize upcoming and past events in order to time the market based on Immunic noise-free hype analysis.
Immunic stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Immunic earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Immunic that are available to investors today. That information is available publicly through Immunic media outlets and privately through word of mouth or via Immunic internal channels. However, regardless of the origin, that massive amount of Immunic data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immunic news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immunic relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immunic's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immunic alpha.

Immunic Largest EPS Surprises

Earnings surprises can significantly impact Immunic's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-08
2024-03-31-0.26-0.3-0.0415 
2023-05-11
2023-03-31-0.52-0.58-0.0611 
2020-11-05
2020-09-30-0.63-0.7-0.0711 
2021-02-26
2020-12-31-0.6-0.460.1423 
2021-08-06
2021-06-30-0.67-0.82-0.1522 
2019-11-07
2019-09-30-0.67-0.82-0.1522 
View All Earnings Estimates

Immunic Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Immunic Stock. Current markets are strongly bearish. About 89% of major world exchanges and indexes are down. See today's market update for more information.
Yahoo News
3rd of March 2025
Immunic to Participate in Scientific and Investor Conferences in March
at finance.yahoo.com 
news
19th of February 2025
Immunic, Inc. Short Interest Update
at thelincolnianonline.com 
news
3rd of February 2025
Sees Rising Short Interest and Institutional Activity
at kalkinemedia.com 
Macroaxis News
16th of January 2025
Disposition of 9986 shares by Howson Tamar D of Immunic at 9.54 subject to Rule 16b-3
at MacroaxisInsider 
Google News at Macroaxis
18th of December 2024
Immunic, Inc. Given Consensus Recommendation of Buy by Brokerages - MarketBeat
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunic's short interest history, or implied volatility extrapolated from Immunic options trading.

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.